AHCOAdaptHealth Corp.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

AdaptHealth’s second quarter results prompted a significant negative market reaction, as the company reported both revenue and profitability well below Wall Street’s expectations. Management attributed this to a combination of operational inefficiencies in its large West Coast capitated contract and cost pressures from a sudden supplier price increase. CEO Suzanne Foster described the unexpected operational challenges as “not sustainable,” highlighting elevated costs from higher-than-anticipated

CEO Foster discusses West Coast operational challenges and a $30M manufacturer price increase.

Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds.

AdaptHealth (NASDAQ:AHCO) executives outlined the company’s second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion. Chief Executive Officer Suzanne Foster said the company has spen

AdaptHealth delivered news to investors this week that crushed its share price.

Moby summary of AdaptHealth Corp.'s Q2 2026 earnings call

Crude oil retreated amid diplomatic optimism over the Strait of Hormuz, as earnings strength lifted equities, today, Aug. 4, 2026.

AdaptHealth Corp (AHCO) navigates a transformative quarter with diabetes divestiture and Humana expansion, despite facing significant contract and pricing challenges.

Healthcare stocks were lower late Tuesday afternoon, with the NYSE Healthcare Index down 0.7% and th

Better Home & Finance (BETR) expects annualized cost cuts to exceed $45 million by year-end, from th

AdaptHealth (NASDAQ:AHCO) reported second-quarter revenue growth in its continuing operations but lowered its full-year profitability outlook, citing higher-than-expected costs in its West Coast capitated contract, a supplier price increase and portfolio actions. Chief Executive Officer Suzanne Fos

AdaptHealth Corp. (NASDAQ:AHCO) shares plunged nearly 13% in pre-market trading after the home medical equipment provider reported second-quarter 2026 results that fell short of Wall Street expectations and sharply reduced its financial outlook for the year.

Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) fell short of the market’s revenue expectations in Q2 CY2026, with sales falling 7.5% year on year to $740.3 million. The company’s full-year revenue guidance of $2.87 billion at the midpoint came in 17.7% below analysts’ estimates. Its GAAP loss of $0.99 per share was significantly below analysts’ consensus estimates.

Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) will be reporting earnings this Tuesday before market hours. Here’s what you need to know.

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

Cardinal Health stock has delivered a very strong 334.8% return over the past five years, yet its current checks lean expensive and suggest the recent share price strength may not leave much room for valuation comfort. Over 5 years, Cardinal Health has returned 334.8%, which puts extra focus on whether today's price still reflects a reasonable long term entry point. The push into home based care through the planned Strive Medical and AdaptHealth diabetes acquisitions can support growth...

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Earlier this week, Cardinal Health announced agreements to acquire AdaptHealth's Diabetes Health business and Strive Medical for about US$360 million in cash, aiming to expand its at-Home Solutions footprint in diabetes management and urology. These moves, combined with management’s previously raised profit guidance and a history of earnings outperformance, highlight Cardinal Health’s push to deepen its role in home-based care while emphasizing cost efficiency. Now we’ll examine how Cardinal...

CAH is set to buy two home-care businesses for about $360 million, expanding diabetes and urology reach while targeting first-year EPS accretion.

Cardinal’s acquisitions of Strive Medical and Adapt Health’s diabetes unit are collectively intended to support its at-home care business’s growth strategy.

Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls

The company agreed to buy a diabetes health business and medical supplier Strive Medical to boost its growing in-home solutions unit.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 11.9% over the past six months while the S&P 500 was up 8.7%.